Influence of Reducing Agents on Biosafety and Biocompatibility of Gold Nanoparticles

Dong-Lin Xia,Yu-Fei Wang,Ning Bao,Hong He,Xiao-dong Li,Yan-Pei Chen,Hai-Ying Gu
DOI: https://doi.org/10.1007/s12010-014-1193-7
2014-01-01
Applied Biochemistry and Biotechnology
Abstract:Extensive biomedical applications of nanoparticles are mainly determined by their safety and compatibility in biological systems. The aim of this study was to compare the biosafety and biocompatibility of gold nanoparticles (GNPs) prepared with HEPES buffer, which is popular for cell culture, and sodium citrate, a frequent reducing agent. From experimental results on the body weight and organ coefficients of acute oral toxicity tests, it could be observed that HEPES-prepared GNPs are biologically safer than citric-prepared GNPs at the same dose of 500 μg/kg. The in vitro cell viability was higher for HEPES-prepared GNPs than citric-prepared GNPs at 5.0- and 10.0-ug/mL concentrations. More reactive oxygen species (ROS) were generated in the cell suspension when supplemented with citric-prepared GNPs than HEPES-prepared GNPs when their concentrations were higher than 20 μg/mL. The results stated that HEPES-prepared GNPs had better biosafety and biocompatibility than citric-prepared GNPs. This study not only revealed the influence of reducing agent on biosafety and biocompatibility of nanomaterials but also provided accumulative evidence for nanomaterials in biomedical applications. Graphical Abstract Spherical HEPES-prepared GNPs were prepared, and their biocompatibility and biosafety were compared with those of citrate-prepared GNPs under in vitro and in vivo conditions. Experimental results indicated that HEPES-prepared GNPs had better biosafety and biocompatibility than citric-prepared GNPs. This study indicated that the choice of the reducing agent could be a key factor for the improvement of biological responses of nanoparticles.
What problem does this paper attempt to address?